Professional Seasonal Analysis for Trading

Lexicon Pharmaceuticals, Inc. - Common Stock (LXRX)

Seasonality Analysis

Stocks 27 Years Analyzed

Lexicon Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

14.09%
Avg Annual Return
45.7%
Avg Monthly Win Rate
8/12
Positive Months
27
Years Analyzed

Lexicon Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 2.89%
58%
Moderate
February WORST -6.44%
38%
Very Weak
March 0.59%
42%
Weak
April 0.10%
41%
Weak
May 0.84%
42%
Weak
June BEST 12.76%
54%
Moderate
July 2.02%
54%
Moderate
August -3.91%
42%
Weak
September 2.35%
38%
Weak
October -0.76%
50%
Weak
November -3.93%
42%
Weak
December 7.58%
46%
Weak

Lexicon Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
100
Historical Avg Position
43.72
Deviation
+56.28
Performance
Significantly Above Average

Lexicon Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for LXRX with overlay patterns, custom date ranges, and more.

Create Free Account

Lexicon Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Lexicon Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for LXRX across multiple timeframes.

Create Free Account

About Lexicon Pharmaceuticals, Inc. - Common Stock (LXRX) Seasonality

Lexicon Pharmaceuticals, Inc. - Common Stock (LXRX) has been analyzed using 27 years of historical data to identify seasonal patterns. Classified under Stocks, Lexicon Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Lexicon Pharmaceuticals, Inc. - Common Stock is historically June, with an average return of 12.76% and a win rate of 54%. Conversely, February tends to be the weakest month, averaging -6.44% return.

Looking at the full calendar year, Lexicon Pharmaceuticals, Inc. - Common Stock has an average annual return of 14.09% with an overall monthly win rate of 45.7%. Out of 12 months, 8 typically show positive average returns.

The seasonal pattern for Lexicon Pharmaceuticals, Inc. - Common Stock has a consistency score of 47.3 (Poor), based on 27 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Lexicon Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Lexicon Pharmaceuticals, Inc. - Common Stock (LXRX)?

Historically, June has been the best month for Lexicon Pharmaceuticals, Inc. - Common Stock, with an average return of 12.76% and a win rate of 54%. However, past performance does not guarantee future results.

What is the worst month for Lexicon Pharmaceuticals, Inc. - Common Stock (LXRX)?

Based on historical data, February has been the weakest month for Lexicon Pharmaceuticals, Inc. - Common Stock, with an average return of -6.44%. This is a historical observation and does not guarantee future results.

How reliable is LXRX seasonality data?

The seasonality analysis for Lexicon Pharmaceuticals, Inc. - Common Stock is based on 27 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Lexicon Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use Lexicon Pharmaceuticals, Inc. - Common Stock (LXRX) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.